(1-isopropyl-4-piperidinyl)acetic acid hydrate, 95.0%, 25g

3-Bromo-4-(4-methylpiperazin-1-yl)benzoic acid, 98%, 250mg

(4-Bromo-3-(trifluoromethyl)phenyl)boronic acid, 95.0%, 5g

TRANS-3-FLUORO-4-METHYLPIPERIDINE HCL, 95.0%, 500mg

(3S,4S)-tert-Butyl 3-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate, 95.0%, 5g

(4-(Pyridin-4-ylcarbamoyl)phenyl)boronic acid, 98%, 1g

L(+)-Ascorbic Acid, min. 99%, Ph. Eur., USP, BP, 250 g, plastic packaging.

Over-glasses 5X7, colorless, gun metal, orange, 5X7.01.00.00, 1 Piece

n-(5-Bromopyridin-2-yl)-4-methylbenzenesulfonamide, 97%, 1g

CEFTIZOXIME, 95%, 1g

Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with ethyl (2R,3S)-2-[4-(cyclopentylamino)phenyl]-3-piperidinecarboxylate (2:1), 97%, 5g

9-(2-Ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole>98.0%(HPLC)(T)200mg

Ethyl 3-(3-methyl-N-propylbenzamido)propanoate, 97%, 1g